science
Onyx Scientific Boosts API Manufacturing Capacity in UK
Onyx Scientific, a global small molecule CDMO, is investing more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP suites, taking the total from six to ten, while increasing capacity for commercial API production and [...] The post Onyx Scientific Boosts API Manufacturing Capacity in UK first appeared on World Pharma Today .
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Divers Searching for a Gas Pipeline Route Found a 400-Year-Old Shipwreck Instead
The Daily Galaxy
GPT-6.1 Sol vs GPT-6 Astra: What are the key differences between OpenAI’s models? Check prices, features and more
Mint
Elon Musk weather update tips Tesla Roadster speculation into Plaid Mode
Teslarati
Butterfly wing patterns may trick predators with motion illusions - Devdiscourse
Google News
Gujarat startup's thermal infrared camera to launch aboard SpaceX's 'Falcon 9' rocket on Oct 1
Prokerala